No Data
Is JWIPC Technology (SZSE:001339) Using Too Much Debt?
Zhiwei Intelligence: 2024 Annual Performance Forecast
Zhiwei Asia Vets (001339.SZ): The expected net income for the year 2024 is projected to increase by 220.01% to 311.44%.
On January 20, Gelonghui reported that Asia Vets (001339.SZ) announced its performance forecast for 2024. The net income attributable to shareholders of the listed company is expected to be between 0.105 billion yuan and -0.135 billion yuan, representing a year-on-year growth of 220.01% to 311.44%; the net income attributable to shareholders of the listed company, after deducting non-recurring gains and losses, is expected to be between 87.6 million yuan and -117.6 million yuan, representing a year-on-year growth of 233.80% to 348.12%; the EPS is expected to be between 0.42 yuan/share and 0.54 yuan/share. During the reporting period, the company adhered to the dual ODM+OBM model.
JWIPC Technology (SZSE:001339) Could Be Struggling To Allocate Capital
JWIPC Technology Scraps Share Issuance Plan
Zhiwei Asia Vets (001339.SZ): Termination of the issuance of stocks to specific objects for the 2024 fiscal year using a simplified process.
On November 29, Glonghui reported that Asia Vets (001339.SZ) announced that it would hold the 14th meeting of the second board of directors and the 11th meeting of the second board of supervisors on November 29, 2024, to review and approve the proposal to terminate the issuance of stocks to specific objects through a simplified process for the year 2024. The company decided to terminate the issuance of stocks to specific objects through a simplified process for the year 2024. Since announcing the matter of issuing stocks to specific objects through a simplified process for the year 2024, the company's board of directors, management, and institutions have been actively promoting various tasks. The company is considering the current capital markets.
Returns On Capital Signal Tricky Times Ahead For JWIPC Technology (SZSE:001339)
